Iovance Biotherapeutics, Inc. · 1 month ago
Director, US Policy and Advocacy
United States
Full-time
Onsite
Director/Executive
12+ years expIovance Biotherapeutics is focused on developing innovative cell therapies, and they are seeking a Director of US Policy and Advocacy to lead comprehensive advocacy strategies that shape the public policy environment for their products. The role involves monitoring healthcare legislative trends, developing proactive policy advocacy strategies, and collaborating with various teams to ensure alignment with commercial goals.
BiotechnologyClinical TrialsHealth CareHealth DiagnosticsMedical
Responsibilities
Monitors healthcare legislative trends, understands healthcare policies, assesses implications of policies, and develops strategies that address barriers to provider and patient access
Leads communications on commercial goals and priorities in cell therapy and ensures policy strategies are aligned with these Key areas of support include issue identification; political insights on risks and opportunities; strategy and policy development; advocacy to Federal, State, Local and Administration policymakers; and, building advocacy and coalitions to shape public policy
Understands total cost of care and all aspects of Medicare and Commercial reimbursement (coding, coverage, and payment) for inpatient and outpatient settings across payer segments
Supports development of proactive, comprehensive policy advocacy strategies that include position and message development, coalition building, securing third-party engagement and commentary, direct and indirect advocacy, and creating and disseminating advocacy materials and tools. Coordinate with cross-functional colleagues in the development and execution of these strategies
Continually assesses Federal and State policies to assure that any impact to Iovance is understood and communicated to appropriate stakeholders at Iovance. Proactively address Iovance views with the appropriate policymakers and/or trade organizations
Monitor for new Federal and State policy releases (rules and regulations), quickly review for impact to Iovance and our products, and draft comment letters as necessary to engage in the rulemaking process
Monitor and understand the impact of government price reporting requirements and policies on Iovance products and to inform Iovance business decisions
Actively participate in industry trade organization committee meetings to advocate for Iovance positions and inform relevant internal stakeholders of trade activity and priorities
Collaborates with Market Access team to assess potential changes to Government Payer policies with a focus on Medicare and Working with team to develop contingency plans for policy impact(s)
Stays in close communication with the executive team to proactively discuss policies that may impact Iovance; always being prepared with possible next steps and solutions
Partners with the Commercial Leadership team to proactively identify policies that may be critical to Iovance success, including Commercialization success and therapy access
Partners with Forecasting to incorporate policy changes into Forecasting assumptions
Implements and monitors systems to measure effectiveness and impact of public policy activities on the policy environment and company performance
Manage functional budget and external consultants
Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics
Perform miscellaneous duties as assigned
Qualification
Required
BA or BS degree is required
Minimum of 12+ years of experience in government affairs and policy
Proven track record and expertise at both the State and Federal government levels
Experience working closely with industry trade organizations such as BIO and ARM
Collaborative and can-do approach with cross-functional colleagues, including Commercial, Advocacy, Legal, and Executive leadership
Excellent critical and strategic thinking skills
In-depth knowledge of current US government pricing statutes and regulations including the Inpatient Prospective Payment System, Medicaid Drug Rebate Program, Public Health Service (340B Program), Medicare Part B (Average Sales Price), Federal Supply Schedule Program, and state reporting requirements
Demonstrated negotiation skills and ability to make sound business arguments to influence external decision makers as well as to establish Iovance's reputation as a valued business partner
Preferred
Advanced degree preferred
Company
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.58B2024-02-20Post Ipo Equity· $211M
2023-07-10Post Ipo Equity· $150M
2020-05-27Post Ipo Equity· $603.7M
Leadership Team
Jean-Marc Bellemin
Chief Financial Officer
Cheryl Aranda
Executive Assistant to Chief Medical Officer
Recent News
2025-12-29
2025-12-07
2025-11-11
Company data provided by crunchbase